|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00440960 |
|
Date of registration:
|
26/02/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
March 2007 |
|
Target sample size:
|
|
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00440960 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Single Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Brazil
| | | | | | | |
|
Contacts
|
|
Name:
|
Andre GS Leite, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Brazilian Society of Thoracic Surgery |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- The patients included in this study were referred to FBC for the investigation of
bronchial carcinoma (diagnostic procedure).
- Patients included in the study were classified as ASA I, II and II according to the
anesthetic risk classification of the American Society of Anesthesiologists (ASA).
Exclusion Criteria:
- ASA IV classification of anesthesiology risk
- procedure that lasted longer than 15 minutes
- indication of therapeutic bronchoscopy
- cardiac arrhythmia and / or hypoxemia detected at admission.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Lung Cancer
|
|
Intervention(s)
|
|
Drug: alfentanil
|
|
Drug: lidocaine
|
|
Drug: midazolam
|
|
Drug: propofol
|
|
Secondary ID(s)
|
|
0002.0.297.000-06
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|